BVS Q4 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$158M+2.8% YoY

Gross Profit

$109M68.9% margin

Operating Income

$23M14.7% margin

Net Income

$15M9.3% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+13.9%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$37M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$684M

Total Liabilities

$455M

Stockholders' Equity

$184M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$158M	$154M	+2.8%
Gross Profit	$109M	$103M	+6.0%
Operating Income	$23M	$8M	+190.5%
Net Income	$15M	-$156,000	+9558.3%

Revenue Segments

U.S. Segment

$139M88%

International Segment

$18M12%

Geographic Segments

UNITED STATES

$139M88%

Non-US

$18M12%